Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea

Clinical trial NCT06211049 · COMPLETED

Trial details

NCT number: NCT06211049
Sponsor: Bionorica SE
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Dysmenorrhea

Start date: 2023-12-12
Primary completion: 2025-07-23
Enrollment: 335

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.